Someones comments are reproduced below for everyone to see and analyse for himself. Can u trust this guy. I have altogether stopped responding to him as its not worth wasting ones time on useless craps of this individual.
1173. Khemka Jul 2, 2016 11:28:07 AM IST Some 1 or 2 said, mgl will go bellow 490 , but it don''''''''''''''''t seems so , it may start northward from 520 to 565/575 this month ends .next month end 610 types likely.medium term playing will be a good idea.
1173.2. Khemka Jul 2, 2016 12:24:00 PM IST My target for cover at 496 was only for listing days trading since on listing maximum traders buy early on hope of selling higher at closing but settles ultimately lower.1 may say anything mind changing or but i think monday 538 possible
Now some1 who flip flops so much- can he be trusted? One day up move the person becomes upbeat n predicts it will cross 560 n ultimately 600. Next day the stock moves down n the person says maha turtle. Can move to 490 n below. Now what to believe? Can this person be trusted for a mature view?
Message of Maha turtle pasted below which I forgot to paste in the message above
1200. Khemka Jul 5, 2016 7:32:18 PM IST Reply Maha-turtle all set to dip bellow 500 , so i again back to my old view, will regret again after it breaks 490 labels .after all anyone are not big pundit. Retailers should exit for short-term.
14. Eagleye| Link| Bookmark|
July 6, 2016 11:41:53 AM
IPO Guru (6600+ Posts, 21900+ Likes)
Advanced Enzyme Technologies Limited
Historical Financial Data All figures in INR million
Financial Year 2012-13 Revenue from Operations 2,204 Gross Profit 1,693 Gross Profit Margin (%) 76.8% EBITDA 896 EBITDA Margin (%) 40.6% Profit After Tax 491 PAT Margin (%) 21.9%
Financial Year 2013-14 Revenue from Operations 2,395 Gross Profit 1,924 Gross Profit Margin (%) 80.3% EBITDA 1,038 EBITDA Margin (%) 43.3% Profit After Tax 201 PAT Margin (%) 8.4%
Financial Year 2014-15 Revenue from Operations 2,231 Gross Profit 1,754 Gross Profit Margin (%) 78.6% EBITDA 910 EBITDA Margin (%) 40.8% Profit After Tax 501 PAT Margin (%) 22.4%
Financial Year 2015-16 (for 6 months ended Sept 2015) Revenue from Operations 1,389 Gross Profit 1,060 Gross Profit Margin (%) 76.3% EBITDA 599 EBITDA Margin (%) 43.2% Profit After Tax 352 PAT Margin (%) 25.3%
Will the amount invested in L&T infotech will b unblocked in time and can be used for Advanced enzyme tech if LNT INFOTECH is not allotted?
14.4. Eagleye| Link| Bookmark|
July 6, 2016 3:51:24 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Dear UNK,
LARSEN & TOUBRO INFOTECH LIMITED (Refer Page No 379 of RHP dated 28th June 2016)
08-Jul-16 – Participation by Anchor Investors 11-Jul-16 – Bid/Offer Opening Date 13-Jul-16 – Bid/Offer Closing Date 18-Jul-16 – Finalisation of Basis of Allotment 19-Jul-16 – Unblocking of Funds from ASBA Account 20-Jul-16 – Credit of Equity Shares to Demat Account 21-Jul-16 – Commencement of Trading on NSE/BSE
your target for Equitas may archived soon before diwali, and Press Release by RBI shows very positive effect. so, what could be the next target? is equitas and ujjivan have potential to become HDFC or YES Bank, please provide your vision on its. it would be more beneficial for us. we don''t have hurry to loose such gems.
13.1. Eagleye| Link| Bookmark|
July 6, 2016 11:44:44 AM
IPO Guru (6600+ Posts, 21900+ Likes)
Equitas is on track to convert itself into a BANK by October 2016 ... with this accelerated move ... I am holding with a revised target of Rs350/- per share before Diwali''16
13.2. Khemka| Link| Bookmark|
July 6, 2016 11:56:01 AM
(1000+ Posts, 400+ Likes)
Eagleye better give target of 250 types
13.3. Eagleye| Link| Bookmark|
July 6, 2016 12:04:50 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Khemkaji,
Respects !!!
This is not a stock for short term trades ... its is a long term portfolio stock ...
Having said that ... Let us see how it goes ... I agree that it should react downwards from current levels. However, the trend is northbound ... 1st Resistance is 193-195 ... 2nd Resistance is 220-222
shall review after it decisively crosses 225 ... but 350 toh aayega ... if not by Diwali then by Christmas ... but definitely within 2016
13.4. Eagleye| Link| Bookmark|
July 6, 2016 12:10:03 PM
IPO Guru (6600+ Posts, 21900+ Likes)
Also similarly with your favourite "Ujjivan" ... Ujjivan & Equitas ... will move broadly in a Ratio of 2:1
The DRHP has the data upto September 2015 ... For the updated data upto March 2016 ... we shall have to wait for the RHP ... will keep you updated once it is made available
The DRHP has the data upto September 2015 ... For the updated data upto March 2016 ... we shall have to wait for the RHP ... will keep you updated once it is made available
Once you have done your workings ... Please let us know your "Fair Value" calculation for this Company ... I hope will oblige us.
10. Eagleye| Link| Bookmark|
July 6, 2016 9:57:06 AM
IPO Guru (6600+ Posts, 21900+ Likes)
Advanced Enzymes IPO
Most likely Scenario ... Crystal Ball Gazing ... Nothing official about it (as yet) !!!
Pre-Issue No. of Shares 21,765,600 Shares Post-Issue No. of Shares 22,323,693 Shares
No. of Shares to be Offered For Sale 4,034,470 Shares No. of Shares to be issued as Fresh Issue 558,093 Shares IPO Size - Fresh + OFS (No. of Shares) 4,592,563 Shares
OFS as a % of Post Issue Capital 18.07% Fresh Issue as a % of Post Issue Capital 2.50% IPO as a % of Post Issue Capital 20.57%
Listing gain will be far less compared to quess due to lot size and current GMP. But, good for long term gains due to monopoly business and FII would fancy this stock as it is completely new sector with no peers.
Company is asking fr fy16 PE multiple of 28. If we assume 10% increase in EPS fr next 2 yrs, pe works out to b 25 fr fy17 and 22.92 fr fy18...which seems reasonable ....revenue growth has been flat though fr last 2 yrs...should b subscribed fr listing as well as long term gains....correct me if I am wrong.